Rendo, Jaida .
HRN: 19-38-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2024
CEFUROXIME 1.5GM (VIAL)
10/25/2024
10/26/2024
IV
1.5gm
Q8 X 2 More Doses
Post OP Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes